(+)-alpha-tocopherol multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 (-)-anisomycin multiple interactions ISO RGD:619568 6480464 wogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein] CTD PMID:23246481 (-)-anisomycin increases phosphorylation ISO RGD:619568 6480464 Anisomycin results in increased phosphorylation of CAV1 protein CTD PMID:23246481 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA CTD PMID:25729387 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases expression ISO RGD:619568 6480464 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CAV1 protein CTD PMID:19706615 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:619568 6480464 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; more ... CTD PMID:19706615 13-HPODE increases expression ISO RGD:619568 6480464 13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of CAV1 mRNA CTD PMID:27257344 17beta-estradiol multiple interactions ISO RGD:619568 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA CTD PMID:19619570 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CAV1 mRNA CTD PMID:27174447 17beta-estradiol increases phosphorylation ISO RGD:619568 6480464 Estradiol results in increased phosphorylation of CAV1 protein CTD PMID:18296501 17beta-estradiol decreases expression ISO RGD:619568 6480464 Estradiol results in decreased expression of CAV1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:619568 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553438 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV1 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553438 6480464 [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of CAV1 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:619568 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV1 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV mRNA CTD PMID:15358164 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV mRNA CTD PMID:15358164 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:619568 6480464 Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA CTD PMID:22298810 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of CAV mRNA CTD PMID:19643169 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID multiple interactions ISO RGD:1553438 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA]; more ... CTD PMID:19015640 2-methoxyethanol affects expression EXP 6480464 methyl cellosolve affects the expression of CAV mRNA CTD PMID:19643169 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1553438 6480464 CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; more ... CTD PMID:19265715 more ... 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:619568 6480464 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [CAV1 mutant form results in decreased expression of FYN protein]; more ... CTD PMID:24709675 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CAV mRNA CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1553438 6480464 3,4,3',4'-tetrachlorobiphenyl promotes the reaction [CAV1 protein binds to AHR protein]; more ... CTD PMID:18786521 PMID:20406653 3,3',4,4'-tetrachlorobiphenyl increases expression ISO RGD:1553438 6480464 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CAV1 protein CTD PMID:18786521 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1553438 6480464 tetrabromobisphenol A results in decreased expression of CAV1 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1553438 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA CTD PMID:16054899 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4,4'-diaminodiphenylmethane results in increased expression of CAV1 mRNA CTD PMID:25380136 5-aza-2'-deoxycytidine multiple interactions ISO RGD:619568 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA CTD PMID:17064661 5-aza-2'-deoxycytidine increases expression ISO RGD:619568 6480464 decitabine results in increased expression of CAV1 mRNA CTD PMID:16367923 5-fluorouracil affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil decreases expression ISO RGD:619568 6480464 Fluorouracil results in decreased expression of CAV1 protein CTD PMID:15352031 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CAV1 mRNA CTD PMID:24780913 acetylcholine multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein affects the susceptibility to Acetylcholine] CTD PMID:18178722 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of CAV1 mRNA CTD PMID:12800193 actinomycin D multiple interactions ISO RGD:619568 6480464 Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 aflatoxin B1 increases expression ISO RGD:619568 6480464 Aflatoxin B1 results in increased expression of CAV1 mRNA CTD PMID:27153756 aldehydo-D-glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA; more ... CTD PMID:19816600 aldehydo-D-glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; more ... CTD PMID:19816600 all-trans-retinoic acid decreases expression ISO RGD:619568 6480464 Tretinoin results in decreased expression of CAV1 mRNA CTD PMID:21934132 aminoguanidine decreases expression ISO RGD:619568 6480464 pimagedine results in decreased expression of CAV1 protein CTD PMID:19706615 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CAV1 mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of CAV1 protein CTD PMID:16483693 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of CAV1 mRNA CTD PMID:22352330 antirheumatic drug increases expression ISO RGD:619568 6480464 Antirheumatic Agents results in increased expression of CAV1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1553438 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CAV1 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO RGD:619568 6480464 CAV1 protein inhibits the reaction [arsenite results in increased phosphorylation of MAPK1 protein]; more ... CTD PMID:12640124 arsenite(3-) multiple interactions ISO RGD:1553438 6480464 tyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CAV1 protein] CTD PMID:14511371 arsenite(3-) increases phosphorylation ISO RGD:1553438 6480464 arsenite results in increased phosphorylation of CAV1 protein CTD PMID:14511371 arsenous acid increases expression ISO RGD:619568 6480464 arsenic trioxide results in increased expression of CAV1 mRNA; more ... CTD PMID:17512576 PMID:22521957 arsenous acid decreases expression ISO RGD:619568 6480464 arsenic trioxide results in decreased expression of CAV1 mRNA; more ... CTD PMID:15725085 more ... atrazine increases expression ISO RGD:619568 6480464 Atrazine results in increased expression of CAV1 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:619568 6480464 Benzo(a)pyrene results in increased expression of CAV1 protein CTD PMID:26657896 benzo[a]pyrene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1553438 6480464 Benzo(a)pyrene results in increased expression of CAV1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1553438 6480464 Benzo(a)pyrene results in decreased expression of CAV1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:619568 6480464 Benzo(a)pyrene results in decreased expression of CAV1 mRNA CTD PMID:20106945 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:619568 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAV1 mRNA CTD PMID:19150397 benzo[b]fluoranthene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 beta-carotene decreases expression ISO RGD:619568 6480464 beta Carotene results in decreased expression of CAV1 protein CTD PMID:26733226 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA CTD PMID:18164116 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CAV1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 bisphenol A inhibits the reaction [SIRT1 protein binds to CAV1 protein]; more ... CTD PMID:28067316 bisphenol A decreases acetylation EXP 6480464 bisphenol A results in decreased acetylation of CAV1 protein CTD PMID:28067316 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CAV1 mRNA; more ... CTD PMID:27174447 Bisphenol A diglycidyl ether multiple interactions ISO RGD:619568 6480464 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV1 protein] CTD PMID:16806087 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of CAV1 protein CTD PMID:25933445 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of CAV1 mRNA CTD PMID:12800193 cadmium atom multiple interactions ISO RGD:1553438 6480464 Cadmium promotes the reaction [HMOX1 protein binds to CAV1 protein] CTD PMID:14658758 cadmium dichloride increases expression ISO RGD:619568 6480464 Cadmium Chloride results in increased expression of CAV1 mRNA CTD PMID:26472689 cadmium nitrate decreases expression ISO RGD:619568 6480464 cadmium nitrate results in decreased expression of CAV1 protein CTD PMID:19061949 calcitriol multiple interactions ISO RGD:619568 6480464 Calcitriol results in increased localization of [VDR protein co-treated with CAV1 protein] CTD PMID:20371703 calcium atom affects transport ISO RGD:1553438 6480464 CAV1 protein affects the transport of Calcium CTD PMID:16428350 calcium(0) affects transport ISO RGD:1553438 6480464 CAV1 protein affects the transport of Calcium CTD PMID:16428350 carbamazepine affects expression ISO RGD:619568 6480464 Carbamazepine affects the expression of CAV1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1553438 6480464 Nanotubes, Carbon analog results in decreased expression of CAV1 mRNA CTD PMID:21624382 PMID:25554681 carboxy-PTIO decreases expression ISO RGD:619568 6480464 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased expression of CAV1 protein CTD PMID:19706615 celecoxib increases expression ISO RGD:619568 6480464 Celecoxib results in increased expression of CAV1 protein CTD PMID:18848576 chloropicrin affects expression ISO RGD:619568 6480464 chloropicrin affects the expression of CAV1 mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:619568 6480464 chloropicrin results in decreased expression of CAV1 mRNA CTD PMID:28476498 cholesterol increases transport ISO RGD:619568 6480464 CAV1 protein results in increased transport of Cholesterol CTD PMID:12640124 cholesterol multiple interactions ISO RGD:1553438 6480464 CAV1 protein affects the reaction [Cholesterol affects the localization of APOE protein] CTD PMID:21169230 cholesterol multiple interactions EXP 6480464 Cholesterol promotes the reaction [APOE protein binds to CAV1 protein] CTD PMID:21169230 chromium atom multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]; more ... CTD PMID:19027847 chrysene decreases expression ISO RGD:1553438 6480464 chrysene results in decreased expression of CAV1 mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 ciprofloxacin increases expression ISO RGD:619568 6480464 Ciprofloxacin results in increased expression of CAV1 protein CTD PMID:26947806 cisplatin affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin increases expression ISO RGD:619568 6480464 Cisplatin results in increased expression of CAV1 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CAV1 mRNA CTD PMID:22023808 cisplatin affects expression ISO RGD:1553438 6480464 Cisplatin affects the expression of CAV1 mRNA CTD PMID:21151649 clofibrate affects expression ISO RGD:619568 6480464 Clofibrate affects the expression of CAV1 protein CTD PMID:17961437 cobalt dichloride decreases expression ISO RGD:619568 6480464 cobaltous chloride results in decreased expression of CAV1 mRNA CTD PMID:19320972 coumestrol multiple interactions ISO RGD:619568 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA CTD PMID:19167446 coumestrol increases expression ISO RGD:619568 6480464 Coumestrol results in increased expression of CAV1 mRNA CTD PMID:19167446 cumene decreases expression ISO RGD:1553438 6480464 cumene results in decreased expression of CAV1 mRNA CTD PMID:18648096 cycloheximide multiple interactions ISO RGD:619568 6480464 Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 cyclosporin A decreases expression ISO RGD:619568 6480464 Cyclosporine results in decreased expression of CAV1 mRNA CTD PMID:20106945 PMID:27989131 cylindrospermopsin increases expression ISO RGD:619568 6480464 cylindrospermopsin results in increased expression of CAV1 mRNA CTD PMID:24921660 cyproconazole decreases expression ISO RGD:619568 6480464 cyproconazole results in decreased expression of CAV1 mRNA CTD PMID:26238599 D-glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; more ... CTD PMID:19816600 D-glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA; more ... CTD PMID:19816600 depsipeptide multiple interactions ISO RGD:619568 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA CTD PMID:17064661 desferrioxamine B increases expression ISO RGD:619568 6480464 Deferoxamine results in increased expression of CAV1 protein CTD PMID:16927372 dexamethasone multiple interactions ISO RGD:1553438 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA; more ... CTD PMID:14984747 PMID:16054899 dexamethasone multiple interactions ISO RGD:619568 6480464 [Dexamethasone results in increased expression of CAV1 protein] which results in decreased susceptibility to VEGFA protein CTD PMID:23426970 dexamethasone increases expression ISO RGD:619568 6480464 Dexamethasone results in increased expression of CAV1 mRNA; more ... CTD PMID:23426970 PMID:25047013 diallyl disulfide multiple interactions ISO RGD:619568 6480464 diallyl disulfide promotes the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:20229525 diallyl trisulfide multiple interactions ISO RGD:619568 6480464 diallyl trisulfide promotes the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:20229525 diarsenic trioxide increases expression ISO RGD:619568 6480464 arsenic trioxide results in increased expression of CAV1 mRNA; more ... CTD PMID:17512576 PMID:22521957 diarsenic trioxide decreases expression ISO RGD:619568 6480464 arsenic trioxide results in decreased expression of CAV1 mRNA; more ... CTD PMID:15725085 more ... dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CAV1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CAV1 mRNA CTD PMID:21658437 dioxygen multiple interactions ISO RGD:1553438 6480464 [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX2 mRNA; more ... CTD PMID:24835767 dioxygen increases expression ISO RGD:619568 6480464 Oxygen deficiency results in increased expression of CAV1 mRNA; more ... CTD PMID:18717816 dioxygen multiple interactions ISO RGD:619568 6480464 [Oxygen deficiency co-treated with 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene] results in increased expression of CAV1 protein; more ... CTD PMID:18717816 dioxygen multiple interactions EXP 6480464 [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 mRNA; more ... CTD PMID:16698853 PMID:24835767 dioxygen increases response to substance ISO RGD:1553438 6480464 CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency CTD PMID:24835767 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CAV1 mRNA CTD PMID:21551480 PMID:25152437 dorsomorphin multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA; more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression ISO RGD:1553438 6480464 Doxorubicin results in increased expression of CAV1 mRNA CTD PMID:22008532 equol multiple interactions ISO RGD:619568 6480464 Equol inhibits the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:16840783 ethanol increases expression ISO RGD:619568 6480464 Ethanol results in increased expression of CAV1 mRNA CTD PMID:15963989 ethyl methanesulfonate decreases expression ISO RGD:619568 6480464 Ethyl Methanesulfonate results in decreased expression of CAV1 mRNA CTD PMID:23649840 fenofibrate increases expression ISO RGD:619568 6480464 Fenofibrate results in increased expression of CAV1 mRNA CTD PMID:15314095 formaldehyde decreases expression ISO RGD:619568 6480464 Formaldehyde results in decreased expression of CAV1 mRNA CTD PMID:23649840 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA]; more ... CTD PMID:17091190 furan increases expression EXP 6480464 furan results in increased expression of CAV1 mRNA CTD PMID:27387713 gefitinib increases expression ISO RGD:619568 6480464 gefitinib results in increased expression of CAV1 mRNA; more ... CTD PMID:19288272 genistein decreases expression ISO RGD:619568 6480464 Genistein results in decreased expression of CAV1 mRNA CTD PMID:22228119 geranylgeraniol multiple interactions ISO RGD:619568 6480464 geranylgeraniol inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; more ... CTD PMID:19816600 glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA; more ... CTD PMID:19816600 hydrogen peroxide multiple interactions ISO RGD:619568 6480464 Hydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein]; more ... CTD PMID:12640124 more ... hydrogen peroxide increases phosphorylation ISO RGD:619568 6480464 Hydrogen Peroxide results in increased phosphorylation of CAV1 protein CTD PMID:23246481 PMID:25512378 hydrogen peroxide increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to Hydrogen Peroxide CTD PMID:12640124 hydrogen peroxide increases expression ISO RGD:1553438 6480464 Hydrogen Peroxide results in increased expression of CAV1 mRNA; more ... CTD PMID:12134086 PMID:17108117 hydrogen peroxide multiple interactions ISO RGD:1553438 6480464 [Hydrogen Peroxide co-treated with CAV1 protein] results in increased expression of CDKN1A protein; more ... CTD PMID:12134086 more ... hydrogen peroxide increases expression ISO RGD:619568 6480464 Hydrogen Peroxide results in increased expression of CAV1 mRNA; more ... CTD PMID:18385095 iron atom affects localization EXP 6480464 Iron affects the localization of CAV1 protein CTD PMID:17172471 iron(0) affects localization EXP 6480464 Iron affects the localization of CAV1 protein CTD PMID:17172471 iron(2+) sulfate (anhydrous) affects localization EXP 6480464 ferrous sulfate affects the localization of CAV1 protein CTD PMID:17172471 isoprenaline multiple interactions ISO RGD:1553438 6480464 CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] CTD PMID:18820136 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of CAV1 mRNA CTD PMID:11578147 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CAV1 mRNA CTD PMID:22641619 lipopolysaccharide multiple interactions ISO RGD:619568 6480464 CAV1 mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX1 mRNA]; more ... CTD PMID:24835767 PMID:26357463 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CAV1 protein modified form CTD PMID:26357463 lipopolysaccharide multiple interactions EXP 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]; more ... CTD PMID:26357463 lipopolysaccharide affects expression ISO RGD:1553438 6480464 Lipopolysaccharides affects the expression of CAV1 mRNA; more ... CTD PMID:10948129 lipopolysaccharide multiple interactions ISO RGD:1553438 6480464 CAV1 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX2 mRNA]; more ... CTD PMID:24835767 lipopolysaccharide increases expression ISO RGD:619568 6480464 Lipopolysaccharides results in increased expression of CAV1 protein modified form CTD PMID:26357463 lithocholic acid multiple interactions ISO RGD:619568 6480464 Lithocholic Acid results in increased localization of [VDR protein co-treated with CAV1 protein] CTD PMID:20371703 lysophosphatidylcholine multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]; more ... CTD PMID:27257344 lysophosphatidylcholine increases expression ISO RGD:619568 6480464 Lysophosphatidylcholines results in increased expression of CAV1 mRNA; more ... CTD PMID:27257344 manganese atom decreases expression ISO RGD:1553438 6480464 Manganese results in decreased expression of CAV1 mRNA; more ... CTD PMID:23499988 PMID:23597857 manganese(0) decreases expression ISO RGD:1553438 6480464 Manganese results in decreased expression of CAV1 mRNA; more ... CTD PMID:23499988 PMID:23597857 mercury dibromide increases expression ISO RGD:619568 6480464 mercuric bromide results in increased expression of CAV1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 methotrexate decreases response to substance ISO RGD:619568 6480464 CAV1 mRNA results in decreased susceptibility to Methotrexate CTD PMID:18694510 methotrexate increases expression ISO RGD:619568 6480464 Methotrexate results in increased expression of CAV1 mRNA CTD PMID:21678067 methotrexate affects response to substance ISO RGD:619568 6480464 CAV1 mRNA affects the susceptibility to Methotrexate CTD PMID:22753658 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of CAV1 gene CTD PMID:23303685 methyl beta-cyclodextrin multiple interactions EXP 6480464 methyl-beta-cyclodextrin inhibits the reaction [Lipopolysaccharides results in increased expression of CAV1 protein modified form] CTD PMID:26357463 methyl beta-cyclodextrin multiple interactions ISO RGD:1553438 6480464 methyl-beta-cyclodextrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein] CTD PMID:20060843 methyl methanesulfonate decreases expression ISO RGD:619568 6480464 Methyl Methanesulfonate results in decreased expression of CAV1 mRNA CTD PMID:23649840 mifepristone multiple interactions ISO RGD:619568 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] CTD PMID:15674352 miquelianin multiple interactions ISO RGD:619568 6480464 quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CAV1 mRNA; more ... CTD PMID:24835767 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions ISO RGD:619568 6480464 N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxygen deficiency results in increased expression of CAV1 protein] CTD PMID:18717816 N-acetyl-L-cysteine decreases expression ISO RGD:619568 6480464 Acetylcysteine results in decreased expression of CAV1 CTD PMID:21148404 N-acetyl-L-cysteine multiple interactions ISO RGD:619568 6480464 Acetylcysteine inhibits the reaction [rosiglitazone results in increased expression of CAV1]; more ... CTD PMID:18507034 PMID:21148404 N-acetylsphingosine multiple interactions ISO RGD:619568 6480464 N-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein] CTD PMID:12640124 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1553438 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CAV1 mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:619568 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CAV1 protein CTD PMID:19706615 N-nitrosodiethylamine increases expression ISO RGD:619568 6480464 Diethylnitrosamine results in increased expression of CAV1 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:1553438 6480464 Diethylnitrosamine results in increased expression of CAV1 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CAV1 mRNA; more ... CTD PMID:18364076 PMID:25380136 N-nitrosodimethylamine multiple interactions EXP 6480464 Dimethylnitrosamine promotes the reaction [CAV1 protein binds to NOS3 protein] CTD PMID:18364076 nicotinic acid multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]; more ... CTD PMID:19027847 nimesulide increases expression ISO RGD:619568 6480464 nimesulide results in increased expression of CAV1 protein CTD PMID:18848576 nitric oxide multiple interactions ISO RGD:619568 6480464 [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide; more ... CTD PMID:18296501 PMID:19706615 nitric oxide increases expression ISO RGD:619568 6480464 Nitric Oxide results in increased expression of CAV1 protein CTD PMID:19706615 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of CAV1 mRNA; more ... CTD PMID:25078423 nitroprusside multiple interactions ISO RGD:619568 6480464 Nitroprusside results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; more ... CTD PMID:19706615 nitroprusside increases expression ISO RGD:619568 6480464 Nitroprusside results in increased expression of CAV1 protein CTD PMID:19706615 NS-398 decreases expression ISO RGD:619568 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CAV1 protein CTD PMID:18848576 nystatin multiple interactions ISO RGD:619568 6480464 Nystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein] CTD PMID:17876056 octanoic acid multiple interactions ISO RGD:1553438 6480464 [octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein; more ... CTD PMID:14984747 ouabain decreases expression ISO RGD:619568 6480464 Ouabain results in decreased expression of CAV1 mRNA CTD PMID:28795476 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CAV1 mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1553438 6480464 Ozone results in decreased expression of CAV1 mRNA; more ... CTD PMID:12763052 PMID:18207479 ozone multiple interactions ISO RGD:1553438 6480464 TNF protein affects the reaction [Ozone results in decreased expression of CAV1 protein] CTD PMID:18207479 paclitaxel increases response to substance ISO RGD:619568 6480464 CAV1 mRNA results in increased susceptibility to Paclitaxel CTD PMID:16322897 paracetamol decreases expression ISO RGD:1553438 6480464 Acetaminophen results in decreased expression of CAV1 protein CTD PMID:20100502 paracetamol increases response to substance ISO RGD:1553438 6480464 CAV1 results in increased susceptibility to Acetaminophen CTD PMID:20100502 paracetamol decreases expression ISO RGD:619568 6480464 Acetaminophen results in decreased expression of CAV1 mRNA CTD PMID:21420995 paracetamol multiple interactions ISO RGD:1553438 6480464 CAV1 affects the reaction [Acetaminophen results in increased expression of BIRC5 protein]; more ... CTD PMID:20100502 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CAV1 mRNA; more ... CTD PMID:26813466 phenethyl isothiocyanate decreases expression ISO RGD:619568 6480464 phenethyl isothiocyanate results in decreased expression of CAV1 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:1553438 6480464 Phenobarbital affects the expression of CAV1 mRNA CTD PMID:23091169 phenylephrine multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Phenylephrine] CTD PMID:18178722 phenylmercury acetate increases expression ISO RGD:619568 6480464 Phenylmercuric Acetate results in increased expression of CAV1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 pioglitazone affects expression ISO RGD:619568 6480464 pioglitazone affects the expression of CAV1 protein CTD PMID:17961437 pirinixic acid multiple interactions ISO RGD:1553438 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CAV1 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:619568 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CAV1 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:619568 6480464 Piroxicam results in decreased expression of CAV1 mRNA CTD PMID:21858171 potassium chloride multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Potassium Chloride] CTD PMID:18178722 progesterone increases expression ISO RGD:619568 6480464 Progesterone results in increased expression of CAV1 mRNA CTD PMID:15674352 progesterone multiple interactions ISO RGD:619568 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] CTD PMID:15674352 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein] CTD PMID:26357463 quercetin multiple interactions ISO RGD:1553438 6480464 Quercetin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein]; more ... CTD PMID:12134086 more ... quercetin decreases expression ISO RGD:1553438 6480464 Quercetin results in decreased expression of CAV1 protein CTD PMID:12134086 quercetin multiple interactions ISO RGD:619568 6480464 Nystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein]; more ... CTD PMID:17876056 more ... quercetin increases expression EXP 6480464 Quercetin results in increased expression of CAV1 protein CTD PMID:16331104 raloxifene multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA]; more ... CTD PMID:17091190 raloxifene affects expression ISO RGD:619568 6480464 Raloxifene Hydrochloride affects the expression of CAV1 mRNA CTD PMID:14699072 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of CAV1 mRNA; more ... CTD PMID:17091190 reactive oxygen species multiple interactions ISO RGD:1553438 6480464 Reactive Oxygen Species promotes the reaction [CAVIN1 protein binds to CAV1 protein] CTD PMID:21705337 resveratrol affects transport ISO RGD:619568 6480464 CAV1 protein affects the transport of resveratrol CTD PMID:19321006 resveratrol multiple interactions ISO RGD:619568 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA; more ... CTD PMID:18296501 PMID:19167446 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CAV1 protein CTD PMID:18266981 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]]; more ... CTD PMID:18266981 resveratrol increases phosphorylation ISO RGD:619568 6480464 resveratrol results in increased phosphorylation of CAV1 protein CTD PMID:18296501 resveratrol increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to resveratrol CTD PMID:19321006 resveratrol increases expression ISO RGD:619568 6480464 resveratrol results in increased expression of CAV1 protein CTD PMID:19321006 rosiglitazone multiple interactions ISO RGD:619568 6480464 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV1 protein]; more ... CTD PMID:15314095 more ... rosiglitazone increases expression ISO RGD:1553438 6480464 rosiglitazone results in increased expression of CAV1 mRNA CTD PMID:17245590 rosiglitazone increases expression ISO RGD:619568 6480464 rosiglitazone results in increased expression of CAV1; more ... CTD PMID:15314095 more ... rosiglitazone multiple interactions ISO RGD:1553438 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA CTD PMID:16054899 SB 203580 multiple interactions ISO RGD:619568 6480464 SB 203580 inhibits the reaction [Hydrogen Peroxide promotes the reaction [SP1 protein results in increased expression of CAV1 protein]]; more ... CTD PMID:17108117 PMID:25512378 SB 203580 multiple interactions ISO RGD:1553438 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein]; more ... CTD PMID:14984747 more ... SB 431542 multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA; more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:619568 6480464 Silicon Dioxide analog results in increased expression of CAV1 mRNA CTD PMID:25895662 simvastatin multiple interactions ISO RGD:619568 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein] CTD PMID:16698853 simvastatin decreases expression ISO RGD:1553438 6480464 Simvastatin results in decreased expression of CAV1 protein CTD PMID:18224302 simvastatin multiple interactions ISO RGD:1553438 6480464 Simvastatin promotes the reaction [[APOA4 protein co-treated with CBS protein] affects the expression of CAV1 protein] CTD PMID:18224302 sodium arsenite multiple interactions ISO RGD:619568 6480464 AKT1 mutant form inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite]; more ... CTD PMID:12640124 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CAV1 protein CTD PMID:19072884 sodium arsenite increases expression ISO RGD:1553438 6480464 sodium arsenite results in increased expression of CAV1 protein CTD PMID:17123562 sodium arsenite decreases expression ISO RGD:1553438 6480464 sodium arsenite results in decreased expression of CAV1 mRNA CTD PMID:16014739 sodium arsenite increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to sodium arsenite CTD PMID:12640124 Soman increases expression EXP 6480464 Soman results in increased expression of CAV mRNA; more ... CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]]; more ... CTD PMID:18266981 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CAV1 protein CTD PMID:18266981 sulfasalazine multiple interactions ISO RGD:1553438 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA]; more ... CTD PMID:19015640 tamoxifen affects expression ISO RGD:619568 6480464 Tamoxifen affects the expression of CAV1 mRNA CTD PMID:14699072 tamoxifen increases expression ISO RGD:619568 6480464 Tamoxifen results in increased expression of CAV1 protein CTD PMID:19288272 taurocholic acid increases secretion ISO RGD:619568 6480464 CAV1 protein results in increased secretion of Taurocholic Acid CTD PMID:14647059 tert-butyl hydroperoxide increases expression ISO RGD:619568 6480464 tert-Butylhydroperoxide results in increased expression of CAV1 mRNA CTD PMID:15963989 testosterone multiple interactions ISO RGD:619568 6480464 [FSHB protein co-treated with Testosterone] results in decreased expression of CAV1 mRNA CTD PMID:18535249 tetrachloromethane increases expression ISO RGD:1553438 6480464 Carbon Tetrachloride results in increased expression of CAV1 mRNA CTD PMID:17484886 tetraphene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 theophylline increases expression ISO RGD:619568 6480464 Theophylline results in increased expression of CAV1 mRNA CTD PMID:16083514 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CAV1 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:1553438 6480464 titanium dioxide results in decreased expression of CAV1 mRNA CTD PMID:23557971 PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA CTD PMID:25729387 trans-resveratrol affects transport ISO RGD:619568 6480464 CAV1 protein affects the transport of resveratrol CTD PMID:19321006 trans-resveratrol multiple interactions ISO RGD:619568 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA; more ... CTD PMID:18296501 PMID:19167446 trans-resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CAV1 protein CTD PMID:18266981 trans-resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]]; more ... CTD PMID:18266981 trans-resveratrol increases phosphorylation ISO RGD:619568 6480464 resveratrol results in increased phosphorylation of CAV1 protein CTD PMID:18296501 trans-resveratrol increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to resveratrol CTD PMID:19321006 trans-resveratrol increases expression ISO RGD:619568 6480464 resveratrol results in increased expression of CAV1 protein CTD PMID:19321006 triadimefon decreases expression ISO RGD:619568 6480464 triadimefon analog results in decreased expression of CAV1 mRNA; more ... CTD PMID:26238599 PMID:26705709 trichostatin A increases expression ISO RGD:619568 6480464 trichostatin A results in increased expression of CAV1 mRNA CTD PMID:24935251 more ... trichostatin A multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:1553438 6480464 trimellitic anhydride results in decreased expression of CAV1 mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CAV1 mRNA CTD PMID:21515302 tyrphostin AG 1478 multiple interactions ISO RGD:619568 6480464 tyrphostin AG 1478 inhibits the reaction [rosiglitazone results in increased expression of CAV1] CTD PMID:18507034 valproic acid decreases expression ISO RGD:619568 6480464 Valproic Acid results in decreased expression of CAV1 mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:619568 6480464 Valproic Acid results in increased expression of CAV1 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:619568 6480464 Valproic Acid results in decreased methylation of CAV1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:619568 6480464 Valproic Acid affects the expression of CAV1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CAV mRNA CTD PMID:19015723 vitamin E multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 vitamin E multiple interactions ISO RGD:1553438 6480464 Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] CTD PMID:12134086 vorinostat increases expression ISO RGD:619568 6480464 vorinostat results in increased expression of CAV1 mRNA CTD PMID:26272509 wogonin multiple interactions ISO RGD:619568 6480464 wogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein]; more ... CTD PMID:23246481 wortmannin multiple interactions ISO RGD:619568 6480464 wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide]; more ... CTD PMID:12640124
Gene-Chemical Interaction Annotations
